Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
BOLT	BOLT BIOTHERAPEUTICS INC	$7.76M	-92.50%	-47.10%	-69.08%	-47.00%	1.14	3.59	100.00%	-433.70%	-433.74%
VVOS	VIVOS THERAPEUTICS INC	$10.61M	-351.30%	-87.40%	-93.94%	-180.60%	9.13	0.78	55.70%	-98.80%	-98.77%
INM	INMED PHARMACEUTICALS INC	$1.88M	-73.60%	-62.00%	-78.71%	-479.70%	0.17	5.94	29.70%	-170.10%	-169.63%
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$23.24M	-70.60%	-55.50%	-75.50%	-361.90%	0.32	7.77	N/A	N/A	N/A
ZJYL	JIN MEDICAL INTERNATIONAL LTD	$15.81M	4.10%	2.40%	4.75%	4.00%	0.80	1.86	29.20%	5.80%	6.80%
LSTA	LISATA THERAPEUTICS INC	$45.25M	-84.40%	-70.80%	-119.59%	-1,297.70%	0.21	5.77	100.00%	-9,756.50%	-10,322.35%
ATNM	ACTINIUM PHARMACEUTICALS INC	$31.22M	-204.40%	-56.60%	-77.36%	1,156.70%	5.61	6.20	100.00%	-37,652.20%	-37,652.22%
BJDX	BLUEJAY DIAGNOSTICS INC	$1.79M	-145.50%	-115.60%	-114.13%	-706.90%	0.19	4.88	N/A	N/A	N/A
BIAF	BIOAFFINITY TECHNOLOGIES INC	$17.23M	-385.20%	-181.80%	-184.01%	-4,117.60%	0.51	2.60	31.40%	-242.00%	-240.53%
AYTU	AYTU BIOPHARMA INC	$29.30M	-107.20%	-19.70%	-37.96%	-254.40%	7.59	1.16	66.80%	-39.00%	-34.20%
BFRG	BULLFROG AI HOLDINGS INC	$21.28M	-273.20%	-208.50%	-303.91%	2,821.40%	0.32	3.85	18.80%	-5,569.60%	-5,564.79%
GUTS	FRACTYL HEALTH INC	$72.66M	N/A	-148.10%	-136.75%	-172.70%	11.84	4.78	N/A	N/A	N/A
DWTX	DOGWOOD THERAPEUTICS INC	$70.48M	-147.80%	-37.80%	-38.96%	6,048.10%	0.20	2.76	N/A	N/A	N/A
BCDA	BIOCARDIA INC	$13.24M	-28,372.40%	-238.20%	-838.74%	572.10%	2.81	1.12	N/A	N/A	N/A
BMRA	BIOMERICA INC	$6.40M	-83.70%	-61.40%	-90.55%	-174.10%	0.36	3.25	5.60%	-90.30%	-90.09%
BNBX	BNB PLUS CORP	$3.49M	-726.30%	-586.80%	-171.96%	-771.50%	0.12	2.32	25.50%	-3,438.00%	-1,549.21%
ZTEK	ZENTEK LTD	$56.69M	-61.30%	-45.40%	-58.04%	-56.00%	0.41	1.00	57.10%	-857.10%	-865.02%
BBLG	BONE BIOLOGICS CORP	$1.97M	-59.50%	-55.70%	-57.81%	-9,521.30%	0.08	13.85	N/A	N/A	N/A
CABR	CARING BRANDS INC	$16.80M	N/A	N/A	N/A	N/A	0.22	0.08	N/A	N/A	N/A
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	$44.31M	N/A	N/A	N/A	N/A	0.47	1.49	N/A	N/A	N/A
CLLS	CELLECTIS SA	$229.32M	-69.40%	-19.50%	-9.47%	-7.40%	3.28	1.62	100.00%	-84.90%	-21.30%
BGMS	BIO GREEN MED SOLUTION INC	$5.52M	-273.20%	-230.30%	-43.65%	-471.20%	0.20	4.70	18.50%	-1,886.50%	-400.40%
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	$6.28M	-139.10%	-45.20%	-36.10%	-1,570.70%	0.41	3.58	-69.20%	-9,335.70%	-9,305.22%
CURX	CURANEX PHARMACEUTICALS INC	$14.49M	-64.50%	-61.20%	-36.85%	-98.60%	0.03	81.94	N/A	N/A	N/A
BMGL	BASEL MEDICAL GROUP LTD	$11.08M	-177.90%	-66.10%	-127.36%	-62.40%	2.44	1.31	77.50%	-94.00%	-95.84%
BLRX	BIOLINERX LTD	$12.01M	-6.00%	-2.80%	0.36%	3.50%	0.97	1.95	80.50%	-99.60%	8.90%
CMND	CLEARMIND MEDICINE INC	$1.56M	-207.50%	-100.70%	-80.17%	383.20%	0.35	3.79	N/A	N/A	N/A
BFRI	BIOFRONTERA INC	$9.42M	-1,139.00%	-52.20%	-60.35%	-120.20%	1.73	1.52	73.70%	-25.30%	-24.12%
APM	APTORUM GROUP LTD	$6.48M	-6.20%	-7.80%	-8.99%	-8.90%	0.21	0.78	N/A	N/A	N/A
ALLR	ALLARITY THERAPEUTICS INC	$17.24M	-85.30%	-49.90%	-112.39%	234.00%	0.86	2.13	100.00%	-3,509.70%	-3,451.88%
ESLA	ESTRELLA IMMUNOPHARMA INC	$45.23M	N/A	-431.00%	126.01%	158.90%	-1.31	0.12	N/A	N/A	N/A
ANTX	AN2 THERAPEUTICS INC	$122.92M	-55.00%	-49.10%	-66.08%	-78.30%	0.17	6.87	N/A	N/A	N/A
APUS	APIMEDS PHARMACEUTICALS US INC	$22.50M	-139.60%	-102.80%	-61.93%	-990.20%	0.13	8.34	N/A	N/A	N/A
ACLX	ARCELLX INC	$6.71B	-55.40%	-36.20%	-50.64%	-51.20%	0.50	4.44	100.00%	-1,027.30%	-1,135.61%
AMIX	AUTONOMIX MEDICAL INC	$4.45M	-228.80%	-186.70%	-200.84%	1,375.80%	0.19	6.18	N/A	N/A	N/A
ALZN	ALZAMEND NEURO INC	$4.03M	-192.40%	-152.20%	-322.04%	3,265.40%	0.85	1.99	N/A	N/A	N/A
AZTR	AZITRA INC	$3.79M	-344.60%	-228.40%	-276.43%	-648.90%	0.32	2.83	N/A	N/A	N/A
ADVB	ADVANCED BIOMED INC	$4.93M	87.30%	55.00%	45.70%	233.90%	0.14	8.56	N/A	N/A	N/A
BDX	BECTON DICKINSON & CO	$44.77B	6.90%	3.20%	5.60%	8.90%	1.17	1.05	46.10%	8.00%	11.77%
IMCC	IM CANNABIS CORP	$2.18M	-498.70%	-27.90%	340.31%	-73.40%	-9.48	0.67	17.70%	-20.70%	-14.11%
BRTX	BIORESTORATIVE THERAPIES INC	$6.93M	-420.30%	-199.40%	-3,992.21%	-892.30%	10.44	0.84	93.40%	-3,959.40%	-3,959.40%
GCTK	GLUCOTRACK INC	$1.26M	-393.30%	-215.70%	-630.70%	1,333.40%	1.77	1.61	N/A	N/A	N/A
KTTA	PASITHEA THERAPEUTICS CORP	$18.51M	-85.50%	-77.40%	-36.96%	1,909.20%	0.09	11.35	N/A	N/A	N/A
GNTA	GENENTA SCIENCE SPA	$12.87M	-60.10%	-42.90%	-43.58%	-52.50%	0.78	13.20	N/A	N/A	N/A
CNSP	CNS PHARMACEUTICALS INC	$1.94M	-164.60%	-130.10%	-350.14%	2,095.30%	0.91	1.98	N/A	N/A	N/A
COCH	ENVOY MEDICAL INC	$51.13M	N/A	-309.70%	737.88%	-235.10%	-1.67	0.54	-262.70%	-11,892.90%	-9,197.51%
CODX	CO-DIAGNOSTICS INC	$6.70M	-125.50%	-109.60%	-228.80%	-494.30%	0.20	3.87	64.30%	-7,533.60%	-7,793.22%
APRE	APREA THERAPEUTICS INC	$8.74M	-96.30%	-74.30%	-100.63%	625.40%	0.28	5.63	100.00%	-4,409.20%	-4,637.35%
HCWB	HCW BIOLOGICS INC	$972.58k	N/A	-80.10%	791.18%	-138.60%	-13.08	0.06	100.00%	-26,308.90%	-13,260.47%
ARTL	ARTELO BIOSCIENCES INC	$5.37M	N/A	-344.80%	1,013.84%	383.00%	-3.20	0.17	N/A	N/A	N/A
AKAN	AKANDA CORP	$101.66k	-56.60%	-27.50%	-66.04%	-3,415.80%	0.88	1.26	9.60%	-619.50%	-619.14%
AIMD	AINOS INC	$10.10M	-140.10%	-63.00%	-71.03%	-122.50%	1.76	1.06	82.90%	-11,897.00%	-11,323.01%
ICCC	IMMUCELL CORP	$57.27M	-3.60%	-2.30%	-2.67%	-2.00%	0.57	4.26	41.40%	-3.80%	-3.72%
INKT	MINK THERAPEUTICS INC	$49.43M	N/A	-180.10%	-807.47%	238.30%	-2.11	1.08	N/A	N/A	N/A
AIM	AIM IMMUNOTECH INC	$4.77M	N/A	-257.80%	2,974.21%	475.60%	-1.59	0.53	-45.50%	-15,861.40%	-14,938.64%
AHG	AKSO HEALTH GROUP	$1.95B	-68.00%	-63.80%	-83.31%	-193.00%	0.07	1.53	1.00%	-914.10%	-1,122.78%
ZSTK	ZEROSTACK CORP	$15.02M	-332.00%	-192.10%	-98.25%	-199.70%	0.85	1.01	4.60%	-335.60%	-334.89%
ADTX	ADITXT INC	$68.46k	-757.20%	-156.60%	472.06%	-351.20%	-2.67	0.02	-1,111.20%	-710,498.70%	-703,444.47%
FOLD	AMICUS THERAPEUTICS INC	$4.54B	-12.00%	-3.20%	6.51%	6.50%	2.46	2.84	88.50%	-4.30%	7.31%
FONR	FONAR CORP	$121.67M	4.10%	3.30%	5.22%	5.90%	0.31	10.00	40.80%	6.70%	9.98%
ADIL	ADIAL PHARMACEUTICALS INC	$2.56M	-182.30%	-141.30%	-151.18%	2,490.20%	0.27	4.43	N/A	N/A	N/A
GDTC	CYTOMED THERAPEUTICS LTD	$11.54M	-42.40%	-38.10%	-47.70%	-75.20%	0.16	5.81	84.10%	-1,629.20%	-1,619.98%
GLMD	GALMED PHARMACEUTICALS LTD	$2.68M	-47.80%	-42.60%	-49.15%	-68.70%	0.13	7.98	N/A	N/A	N/A
HSCS	HEARTSCIENCES INC	$8.01M	-333.40%	-140.20%	-236.78%	-632.60%	1.85	1.19	57.90%	-97,881.00%	-89,741.82%
IMMP	IMMUTEP LTD	$51.73M	-61.80%	-50.90%	-83.72%	-144.80%	0.49	2.97	100.00%	-777.70%	-777.30%
ADGM	ADAGIO MEDICAL HOLDINGS INC	$25.54M	-312.00%	-66.00%	-63.33%	-115.80%	2.49	2.44	N/A	N/A	N/A
MGRX	MANGOCEUTICALS INC	$5.01M	-116.30%	-108.00%	-128.36%	2,022.00%	0.05	0.74	60.60%	-4,308.30%	-4,323.88%
ABVC	ABVC BIOPHARMA INC	$24.68M	-88.90%	-43.10%	-50.13%	-57.40%	0.70	0.41	N/A	N/A	N/A
PIII	P3 HEALTH PARTNERS INC	$22.22M	N/A	-20.70%	-81.60%	83.10%	-5.13	0.24	-5.40%	-10.10%	-6.23%
ITOC	ITONIC HOLDINGS LTD	$5.97M	-82.80%	-64.50%	-59.05%	-319.70%	0.16	8.83	62.60%	-974.70%	-974.68%
SILO	SILO PHARMA INC	$5.10M	-83.50%	-63.70%	-60.25%	-283.50%	0.21	11.36	38.60%	-5,863.50%	-5,811.76%
SRXH	SRX HEALTH SOLUTIONS INC	$38.47M	N/A	-188.70%	-1,175.68%	-751.00%	6.68	0.80	14.60%	304.30%	315.42%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$2.23B	-187.60%	-37.80%	-51.15%	-67.80%	1.99	1.79	91.50%	-216.50%	-205.84%
ACXP	ACURX PHARMACEUTICALS INC	$10.59M	-215.60%	-128.70%	-151.21%	339.50%	0.46	3.18	N/A	N/A	N/A
TELO	TELOMIR PHARMACEUTICALS INC	$44.70M	-315.20%	-259.30%	-176.10%	1,626.80%	0.24	5.14	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	606	+5.53%	+5.59%	-1.06%	-28.44%	26.93x	4.73x	-36.99%	-13.81%	-7.67%	+63.66%	Strong Buy
Diagnostics & Research	55	+2.65%	+0.66%	-4.87%	+8.98%	20.57x	3.64x	-2.96%	+6.69%	+13.04%	+27.71%	Strong Buy
Drug Manufacturers - General	20	+2.02%	+2.66%	-6.77%	+18.01%	33.08x	6.99x	+8.30%	+12.35%	+21.01%	+18.84%	Buy
Drug Manufacturers - Specialty & Generic	75	+4.06%	+2.48%	-5.84%	-26.57%	-126.97x	1.62x	+9.76%	+2.97%	+7.84%	+42.31%	Strong Buy
Healthcare Plans	10	+3.14%	-0.57%	-7.91%	-37.80%	22.30x	1.76x	+9.16%	+2.87%	+7.00%	+29.33%	Buy
Health Information Services	55	+2.37%	-2.53%	-9.46%	-82.91%	23.11x	2.81x	-7.12%	+2.47%	+4.85%	+62.34%	Buy
Medical Care Facilities	50	+0.55%	-1.55%	-9.89%	-44.10%	18.29x	5.31x	-68.68%	+7.39%	+19.07%	+24.34%	Buy
Medical Devices	137	+2.04%	-1.34%	-10.05%	-66.16%	24.00x	3.27x	+8.76%	+5.30%	+9.42%	+55.57%	Strong Buy
Medical Distribution	10	+1.06%	-1.69%	-12.34%	+25.77%	29.03x	304.82x	-99.87%	+3.28%	+23.33%	+16.54%	Strong Buy
Medical Instruments & Supplies	57	+2.41%	+0.23%	-7.59%	-9.11%	-487.35x	3.40x	+9.43%	+7.52%	+4.13%	+31.91%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 17 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock lose -0.22% over the past year, overperforming other healthcare stocks by 36 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 64.29% from Bioventus's current stock price of $9.13.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: C, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 35, which is 8 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 48.33% over the past year, overperforming other healthcare stocks by 85 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $15.00, an upside of 20.68% from Amneal Pharmaceuticals's current stock price of $12.43.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Trubridge (NASDAQ:TBRG)

Trubridge (NASDAQ:TBRG) is the #3 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Trubridge (NASDAQ:TBRG) is: Value: A, Growth: B, Momentum: D, Sentiment: A, Safety: B, Financials: B, and AI: B.

Trubridge (NASDAQ:TBRG) has a Due Diligence Score of 32, which is 5 points higher than the healthcare sector average of 27. It passed 12 out of 38 due diligence checks and has average fundamentals. Trubridge has seen its stock lose -46.8% over the past year, underperforming other healthcare stocks by -10 percentage points.

Trubridge has an average 1 year price target of $23.00, an upside of 57.1% from Trubridge's current stock price of $14.64.

Trubridge stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Trubridge, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 268.46%, which is 263 percentage points higher than the healthcare sector average of 5.7%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 20.46%, which is 15 percentage points higher than the healthcare sector average of 5.7%.

Dominari Holdings's dividend payout ratio of -42.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.47%, which is 6 percentage points higher than the healthcare sector average of 5.7%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 162.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 3.39% in the last day, and up 1.95% over the last week. Apellis Pharmaceuticals was the among the top gainers in the healthcare sector, gaining 135.4% yesterday.

Apellis Pharmaceuticals share are trading higher after the company announced that it will be acquired by Biogen for $41 per share.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -30.67% in the past year. It has overperformed other stocks in the healthcare sector by 6 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 138.78% in the past year. It has overperformed other stocks in the healthcare sector by 175 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -15.61% in the past year. It has overperformed other stocks in the healthcare sector by 21 percentage points.

Are healthcare stocks a good buy now?

59.06% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.58% over the next year.

5.71% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.28% of healthcare stocks are rated B (Buy), 50.25% are rated C (Hold), 23.95% are rated D (Sell), and 6.82% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is -5.86x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Trubridge (NASDAQ:TBRG)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Trubridge (NASDAQ:TBRG)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.